Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2c342c3313734b86a7b48be92151bc54 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e54c3d0729ddb81bbe19ecfe188bd6b2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c516eebbb826433856340423d1be5839 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_43a72884e25aaecffebe0942132d704f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca32fd2a44fd326ffd027a75a57bd13f http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1466a7f6f56f0dee16e60318ceedc197 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_612801a8c076874181dc5fdaa62ea2c7 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-908 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-38 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-975 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2469-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-922 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6854 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56961 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 |
filingDate |
2006-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_144871a6d65b3dfdec756445466e8120 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1493b052002cb4565a5a15c210a84ea2 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_24b9c5bd87b9ac16885cb3d691f2705d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_62f7b85f406fdd49942d98f3d949186c http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_638b5ce805147ae0650de07917f16fb3 |
publicationDate |
2007-02-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2007015177-A2 |
titleOfInvention |
In vitro diagnostic method and kit for an aspergillus infection |
abstract |
The present invention relates to a method for the in vitro diagnosis of an Aspergillus infection by determining in the serum or plasma sample of a subject the quantity of antibodies directed against a combination of at least two of the ribonuclease (RNU), catalase (CA) and dipeptidylpeptidase V (DPPV) Aspergillus antigens. The invention also relates to a diagnostic kit comprising said combination. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10107822-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011063395-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011063395-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10585098-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10288611-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11079380-B2 |
priorityDate |
2005-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |